What Is Pre-IPO Investing, and Who Actually Gets Access?
Pre-IPO investing means buying private shares before a listing. Here is how access actually works, who qualifies, and what the real risks are.
When SpaceX priced its most recent private round at a valuation near 1.8 trillion US dollars, a question that institutional investors have quietly asked for years suddenly reached a much wider audience: how does anyone actually get a piece of a company like this before it lists?
Pre-IPO investing has existed for decades, but it rarely came up outside venture capital and private banking circles. As more household names, from Anduril to OpenAI to SpaceX itself, stay private for ten years or longer while reaching very large private valuations over extended periods, the question of who gets access, and how, has become relevant to a far broader group of investors.
This guide explains what pre-IPO investing actually involves, how the access layer works in practice, who legally qualifies to participate, and what the real risks look like once the headlines are stripped away.
What does pre-IPO investing actually mean?
Pre-IPO investing means acquiring equity in a company before its shares list on a public stock exchange. It is sometimes labeled growth equity or late-stage private investing, but the underlying mechanic is the same: capital changes hands while the company is still privately held and not yet subject to public reporting requirements or open market trading.
There are two main routes into a position. The first is a primary round, where new capital is issued directly to the company in exchange for newly created shares, typically structured as a Series C, D, or later financing round. The second is a secondary transaction, where an existing shareholder, often an early employee or early investor, sells shares they already hold to a new buyer. No new capital reaches the company in a secondary sale; ownership simply changes hands.
How does a company end up offering pre-IPO access at all?
Late-stage private rounds exist because growth companies need capital to keep scaling without the disclosure obligations, market scrutiny, and quarterly earnings pressure that come with being public. A company like Anduril has raised successive rounds at rapidly increasing valuations partly because staying private gives founders more control over timing and strategy.
As these rounds grow larger and the investor base widens, room opens for outside capital, either directly in the round itself or through secondary purchases from existing holders seeking liquidity ahead of any eventual IPO. Specialized investment firms may participate in these transactions through relationships with venture funds, existing shareholders, or other market participants, although access varies significantly across firms and transactions.
Who actually qualifies to invest pre-IPO?
This is where most of the confusion lives. Private securities are not freely tradable to the general public, and most jurisdictions set a clear legal bar for participation.
In the United States, the relevant test is whether someone qualifies as an accredited investor under SEC Regulation D. As of 2026, that generally means annual income above 200,000 US dollars (300,000 for joint income) in each of the last two years, or net worth above 1 million US dollars excluding the value of a primary residence. Certain professional licenses, such as being a registered securities representative, can also qualify someone independent of income or net worth.
In Switzerland and the EU, the comparable concepts are the qualified investor classification under the Collective Investment Schemes Act and the professional or institutional client classification under FinSA, both carrying their own wealth, experience, and sophistication thresholds rather than mirroring the US test directly.
Meeting one of these thresholds does not guarantee an allocation. Late-stage rounds in companies with strong demand are frequently oversubscribed several times over, and companies and lead investors choose who participates, often prioritizing existing relationships ahead of new capital.
Why has the secondary market for private shares grown so quickly?
A functioning secondary market for private company shares barely existed two decades ago. It now has become a more widely used channel for late-stage access, driven largely by employees and early investors at long-staying private companies who want some liquidity without waiting for an eventual IPO.
Specialized marketplaces and intermediaries now may facilitate these transactions, though pricing is typically negotiated rather than continuously quoted, and most sales require the company’s consent under a right of first refusal clause built into standard shareholder agreements.
What are the real risks of pre-IPO investing?
Three risks matter more than any others.
Illiquidity comes first. There is no guarantee of a buyer if an investor needs to exit before an IPO, acquisition, or approved secondary sale, and that wait can run into years.
Valuation opacity comes second. Private valuations are set periodically through negotiated funding rounds rather than continuous trading, so the price paid may not reflect current business performance, and there is no daily market price against which to check it.
Limited disclosure comes third. Private companies are not required to publish the financial detail that public companies must disclose, so investors typically rely on whatever information the company or intermediary chooses to share.
How should pre-IPO exposure fit into a broader portfolio?
Given the combination of illiquidity, concentration, and limited information, most experienced investors treat pre-IPO positions as a smaller, satellite allocation rather than a core portfolio holding, sized in proportion to overall liquidity needs and risk tolerance rather than the size of the headline opportunity. How that exposure is held — whether through direct investments, pooled vehicles, or fund access — further shapes its role in a portfolio.
Key takeaways
- Pre-IPO investing means buying private company shares before a public listing, either through a primary round or a secondary purchase from an existing shareholder
- Access is legally restricted to accredited investors in the US, and to qualified or professional investors in Switzerland and the EU
- Meeting an investor threshold does not guarantee an allocation, since late-stage rounds are frequently oversubscribed
- The main risks are illiquidity, valuation opacity, and limited company disclosure
- Most investors size pre-IPO exposure as a smaller, satellite position rather than a core holding
Frequently Asked Questions
Summary
Pre-IPO investing gives investors a way to participate in a company’s growth before it lists publicly, but the access layer is legally restricted, allocations are scarce, and the risks, particularly illiquidity and limited disclosure, are real. Understanding how primary rounds, secondary sales, and investor qualification rules actually work is essential before evaluating any specific opportunity, regardless of how well known the company’s name might be.
Goldbach Capital is the private markets arm of Alpen Partners, your FINMA-licensed Swiss independent asset manager and family office. We give qualified investors curated access to pre-IPO equity, private credit, and alternative investments through direct deals, pooled vehicles, and select third-party manager partnerships.